NB.1.8.1: The Rise of a New COVID-19 Variant
NB.1.8.1 (“Nimbus”) is now the most infectious SARS-CoV-2 variant in circulation. Learn how it affects clinical practice, immunity, and public health in 2025.
Read moreNB.1.8.1 (“Nimbus”) is now the most infectious SARS-CoV-2 variant in circulation. Learn how it affects clinical practice, immunity, and public health in 2025.
Read moreThis year’s King’s Birthday Honours celebrate the quiet, enduring impact of rural general practice in Australia, spotlighting two GPs whose legacy goes far beyond medicine.
Read moreA consumer report has cast doubt on popular sunscreens, but the TGA urges confidence in Australia’s rigorous SPF testing standards. We explore the facts behind the claims.
Read moreWith VAD laws now active across all Australian states, clinicians face a new frontier in end-of-life care. This article explores access, ethics, AMA guidance, and the role of education.
Read moreAustralia’s public hospital system is facing critical pressure. The AMA proposes a $27.8B plan to reverse worsening delays, overcrowding, and burnout.
Read moreAs NDIS fraud escalates, healthcare professionals can play a vital role in early detection and prevention. Here’s how GPs can support patients at risk.
Read moreWith record RSV cases in infants, Australia’s dual immunisation strategy offers real hope. Learn how maternal vaccination and infant antibodies can prevent RSV hospitalisation.
Read moreThe Albanese Government’s $8.5B Medicare plan expands bulk-billing incentives and aims to boost GP access while raising questions about viability for practices.
Read moreThe DRAW program integrates cultural knowledge, shared medical visits, and real-time glucose monitoring to help First Nations women manage and even reverse T2DM.
Read moreWhile most recover fully from COVID-19, some experience lasting lung damage. Explore the latest research on post-COVID fibrosis, treatment, and transplantation.
Read more